Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Nieuwe cijfers Alzheimer Europe: aantal mensen met dementie in 2050 verdubbeld
feb 2020 | Dementie